Doxazosin Mesylate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 12 USDMF, 9 CEP/COS, 7 JDMF, 8 EU WC, 6 KDMF, 8 NDC API, 19 Listed Suppliers, $ API Reference Price

INTERMEDIATES

17 Intermediates Suppliers

17 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

349 FDF Dossiers, 82 FDA Orange Book, 219 Europe, 12 Canada, 9 South Africa, 27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 1MG BASE, TABLET;ORAL - EQ 2MG BASE, TABLET;ORAL - EQ 4MG BASE, TABLET;ORAL - EQ 8MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 4MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 8MG BASE

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 2 Seqens, 4 DKSH, 1 Jai Radhe Sales, 5 Faran Shimi Pharmaceutical, 12 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 5 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 15 BASF, 10 Corel Pharma Chem, 7 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 31 Direct Compression, 28 Disintegrants & Superdisintegrants, 25 Controlled & Modified Release, 21 Granulation, 18 Thickeners and Stabilizers, 15 Co-Processed Excipients, 14 Lubricants & Glidants, 9 Taste Masking, 8 Topical, 7 Film Formers & Plasticizers, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 Coloring Agents, 5 Solubilizers, 5 Parenteral, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Emulsifying Agents, 3 Rheology Modifiers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 11 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 200 Finished Drug Prices, 3 Annual Reports

MARKET PLACE

7 APIs, 2 FDF Dossiers, 1 Intermediates

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 4 JP, 9 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 19668 / DOSAGE - TABLET;ORAL - EQ 1MG BASE

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
DOXAZOSIN MESYLATE(UNII: 86P6PQK0MU) (DOXAZOSIN - UNII:NW1291F1W8)	DOXAZOSIN	1mg

Inactive Ingredients

Ingredient Name	A-S Medication Solutions	AvPAK	Golden State Medical Supply, Inc.	Par Pharmaceutical	REMEDYREPACK INC.	Bryant Ranch Prepack	Cardinal Health	Major Pharmaceuticals	Mylan Institutional Inc.	Mylan Pharmaceuticals Inc.	NCS HealthCare of KY, Inc dba Vangard Labs	PD-Rx Pharmaceuticals, Inc.	APPCO PHARMA LLC	Lake Erie Medical DBA Quality Care Products LLC	Legacy Pharmaceutical Packaging, LLC	NuCare Pharmaceuticals, Inc.	Preferred Pharmaceuticals, Inc	St Marys Medical Park Pharmacy	Preferred Pharmaceuticals, Inc.	Method Pharmaceuticals, LLC	Unit Dose Services
ALUMINUM OXIDE(LMI26O6933)
ANHYDROUS LACTOSE(3SY5LH9PMK)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
CROSCARMELLOSE SODIUM(M28OL1HH48)
D&C RED NO. 30(2S42T2808B)
D&C YELLOW NO. 10(35SW5USQ3G)
FD&C BLUE NO. 2(L06K8R7DQK)
FD&C RED NO. 40(WZB9127XOA)
FD&C YELLOW NO. 6(H77VEI93A8)
FERRIC OXIDE YELLOW(EX438O2MRT)
LACTOSE MONOHYDRATE(EWQ57Q8I5X)
LACTOSE(J2B2A4N98G)
LACTOSE, UNSPECIFIED FORM(J2B2A4N98G)
MAGNESIUM STEARATE(70097M6I30)
MICROCRYSTALLINE CELLULOSE 102(PNR0YF693Y)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
SILICON DIOXIDE(ETJ7Z6XBU4)
SODIUM LAURYL SULFATE(368GB5141J)
SODIUM STARCH GLYCOLATE TYPE A CORN(AG9B65PV6B)
SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)
SODIUM STARCH GLYCOLATE TYPE B POTATO(27NA468985)
STARCH, CORN(O8232NY3SJ)

Drug Product Composition: Doxazosin Mesylate